isoniazid has been researched along with Ankylosing Spondylarthritis in 15 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we investigated the safety and toxicity of isoniazid (INH) intervention therapy to the patients with latent tuberculosis who were given tumor necrosis factor alpha (TNFalpha) for the treatment of their rheumatologic diseases." | 9.12 | Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. ( Hanta, I; Kocabas, A; Kuleci, S; Ozbek, S; Sert, M, 2007) |
| "To investigate associations between isoniazid for latent tuberculosis and risk of severe hepatitis, affecting patients with rheumatoid arthritis or ankylosing spondylitis whose treatment includes tumor necrosis factor inhibitors." | 8.02 | Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors. ( Chao, PH; Chen, WW; Huang, WI; Huang, YC; Lai, EC; Liang, HY; Weng, MY, 2021) |
| "In this study, we investigated the safety and toxicity of isoniazid (INH) intervention therapy to the patients with latent tuberculosis who were given tumor necrosis factor alpha (TNFalpha) for the treatment of their rheumatologic diseases." | 5.12 | Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. ( Hanta, I; Kocabas, A; Kuleci, S; Ozbek, S; Sert, M, 2007) |
| " Of the patients taking isoniazid (INH) for tuberculosis prophylaxis, 47." | 4.31 | Compliance level to Tuberculosis prophylaxis in patients undergoing therapy with tumor necrosis factor-alpha inhibitors: a cross-sectional study. ( Aytac, S; Dogru, S; Ovayolu, O, 2023) |
| "To investigate associations between isoniazid for latent tuberculosis and risk of severe hepatitis, affecting patients with rheumatoid arthritis or ankylosing spondylitis whose treatment includes tumor necrosis factor inhibitors." | 4.02 | Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors. ( Chao, PH; Chen, WW; Huang, WI; Huang, YC; Lai, EC; Liang, HY; Weng, MY, 2021) |
| " We report the case of a 45-year-old man who had ankylosing spondylitis and was receiving infliximab and isoniazid for latent tuberculosis." | 3.74 | Severe sporotrichoid fish tank granuloma following infliximab therapy. ( Chatziolou, E; Frangoulis, E; Katsambas, A; Koumantaki-Mathioudaki, E; Rallis, E, 2007) |
| "A study of latent tuberculosis infection (LTBI) burden by chest roentgenography (CXR) with reference to interferon-gamma release assay (IGRA) is still lacking in rheumatic patients of an intermediate tuberculosis burden area." | 1.56 | Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients. ( Chang, TH; Lin, CH; Wang, PH; Wu, CS, 2020) |
| "We present a 23 year-old male with ankylosing spondylitis, who developed endobronchial and widespread pulmonary tuberculosis, 2 years after initiation of treatment with infliximab." | 1.33 | Delayed response to anti-tuberculosis treatment in a patient on infliximab. ( Iliopoulos, A; Psathakis, K; Tsintiris, K; Vlachaki, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, EC | 1 |
| Liang, HY | 1 |
| Huang, YC | 1 |
| Huang, WI | 1 |
| Chao, PH | 1 |
| Chen, WW | 1 |
| Weng, MY | 1 |
| Aytac, S | 1 |
| Ovayolu, O | 1 |
| Dogru, S | 1 |
| Wang, PH | 1 |
| Lin, CH | 1 |
| Chang, TH | 1 |
| Wu, CS | 1 |
| Baričević, D | 1 |
| Popović Grle, S | 1 |
| Morović Vergles, J | 1 |
| Čuković Čavka, S | 1 |
| Jakopović, M | 1 |
| Redžepi, G | 1 |
| Boras, Z | 1 |
| Baričević, M | 1 |
| Samaržija, M | 1 |
| Pamuk, ON | 1 |
| Yesil, Y | 1 |
| Donmez, S | 1 |
| Unlü, E | 1 |
| Köker, IH | 1 |
| Cakir, N | 1 |
| Wibaux, C | 1 |
| Andrei, I | 1 |
| Paccou, J | 1 |
| Philippe, P | 1 |
| Biver, E | 1 |
| Duquesnoy, B | 1 |
| Flipo, RM | 1 |
| Nobre, CA | 1 |
| Callado, MR | 1 |
| Lima, JR | 1 |
| Gomes, KW | 1 |
| Martiniano, GV | 1 |
| Vieira, WP | 1 |
| MATUSIS, TI | 1 |
| Vlachaki, E | 1 |
| Psathakis, K | 1 |
| Tsintiris, K | 1 |
| Iliopoulos, A | 1 |
| Sichletidis, L | 1 |
| Settas, L | 1 |
| Spyratos, D | 1 |
| Chloros, D | 1 |
| Patakas, D | 1 |
| Hanta, I | 1 |
| Ozbek, S | 1 |
| Kuleci, S | 1 |
| Sert, M | 1 |
| Kocabas, A | 1 |
| Rallis, E | 1 |
| Koumantaki-Mathioudaki, E | 1 |
| Frangoulis, E | 1 |
| Chatziolou, E | 1 |
| Katsambas, A | 1 |
| Blaha, HM | 1 |
| Andrews, RH | 1 |
| Edwards, TA | 1 |
| Davies, D | 1 |
| Gacad, G | 1 |
| Massaro, D | 1 |
1 trial available for isoniazid and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asp | 2007 |
14 other studies available for isoniazid and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors.
Topics: Adult; Aged; Antitubercular Agents; Arthritis, Rheumatoid; Female; Hepatitis; Hospitalization; Human | 2021 |
Compliance level to Tuberculosis prophylaxis in patients undergoing therapy with tumor necrosis factor-alpha inhibitors: a cross-sectional study.
Topics: Adult; Arthritis, Rheumatoid; Cross-Sectional Studies; Female; Humans; Immunologic Factors; Isoniazi | 2023 |
Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Arthritis, Psoriatic; Arthritis, Rheumatoi | 2020 |
QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
Topics: Analysis of Variance; Antirheumatic Agents; Antitubercular Agents; Arthritis, Infectious; Biological | 2017 |
The results of purified protein derivative test in ankylosing spondylitis patients: clinical features, HRCT results and relationship with TNF-blocker usage.
Topics: Adult; Aged; Antibodies, Monoclonal; Antitubercular Agents; Arthritis, Gouty; Arthritis, Rheumatoid; | 2008 |
Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases.
Topics: Adult; Antirheumatic Agents; Antitubercular Agents; Contraceptives, Oral; Drug Interactions; Female; | 2010 |
Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antitubercular Agents; Arthritis, Psoriatic; Ar | 2012 |
[THE EFFECTIVENESS OF ANTIBACTERIAL TREATMENT IN TUBERCULOUS SPONDYLITIS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Child; Drug Therapy; H | 1964 |
Delayed response to anti-tuberculosis treatment in a patient on infliximab.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antitubercular Agents; Drug Interactions; Human | 2005 |
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Ag | 2006 |
Severe sporotrichoid fish tank granuloma following infliximab therapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Environmental Exposure; Gra | 2007 |
Clinical and epidemiological aspects of myocobacterial infection in Western Germany.
Topics: Adult; Aged; Airway Obstruction; Aspergillosis; Carrier State; Dapsone; Female; Germany, West; Human | 1978 |
Progressive lung disease in patients with tuberculosis and ankylosing spondylitis.
Topics: Aged; Aminosalicylic Acids; Aspergillosis; Humans; Isoniazid; Male; Middle Aged; Pulmonary Fibrosis; | 1974 |
Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis.
Topics: Adult; Autopsy; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Myco | 1974 |